Subject category:
Entrepreneurship
Published by:
Harvard Business Publishing
Version: 1 August 2023
Share a link:
https://casecent.re/p/194425
Write a review
|
No reviews for this item
This product has not been used yet
Abstract
Shad Faraz and Alex Youssef were intrigued by the opportunities in the relatively new area of Digital Therapeutics. Despite initial successes, early entrants had struggled with reimbursement and revenue-predictability challenges. However, venture investors still continued to be enthusiastic about the space, prompting Faraz and Youssef to dive headfirst into the world of entrepreneurship and found Sky Therapeutics. Although their decision to pursue their startup full-time was exciting, they also needed to tackle pressing questions and unique challenges around the right clinical problem to target and with what technological and behavioral mechanism. Would the digital therapeutics space flourish or flop, and how would that affect Sky's prospects?
About
Abstract
Shad Faraz and Alex Youssef were intrigued by the opportunities in the relatively new area of Digital Therapeutics. Despite initial successes, early entrants had struggled with reimbursement and revenue-predictability challenges. However, venture investors still continued to be enthusiastic about the space, prompting Faraz and Youssef to dive headfirst into the world of entrepreneurship and found Sky Therapeutics. Although their decision to pursue their startup full-time was exciting, they also needed to tackle pressing questions and unique challenges around the right clinical problem to target and with what technological and behavioral mechanism. Would the digital therapeutics space flourish or flop, and how would that affect Sky's prospects?